A $50,000 Form D filing is not a typical pre-seed round. It is a bootstrap. For Dexorder, a noncustodial on-chain order management system for DeFi traders, that filing on November 19, 2025, is the only public capital event on record [formds.com, Nov 2025]. The company, structured as DEXORDER, LLC in San Juan, Puerto Rico, is betting that a niche of power users on Arbitrum One will pay for advanced trading tools that live entirely on-chain. Founder and CEO Tim Olson, whose background includes algorithmic cryptocurrency trading roles, is the sole listed executive [RocketReach, Unknown] [formds.com, Nov 2025].
The On-Chain Wedge
Dexorder's product claim is specific. It offers limit orders, stop-losses, dollar-cost averaging (DCA), and breakout orders for Uniswap pools on Arbitrum One, with plans to expand to other Layer 2 networks [dexorder.com, Unknown]. The entire stack is EVM-native and noncustodial. The code itself, hosted on a public GitHub repository, is the primary sales asset [github.com, Unknown].
Founder Profile and Early Risks
The venture rests on Tim Olson's shoulders. His LinkedIn profile lists experience at Algorithmic Cryptocurrency Trading, altASIC, Zeropond, and StackLife, suggesting a technical background adjacent to crypto markets [LinkedIn, 2026].
- Capital runway. A $50,000 pre-seed translates to a runway measured in months, not quarters.
- Solo founder load. Product development, business development, and community management for a technical DeFi product is a multi-front war.
- Competitive silence. Gaining visibility without a marketing budget is a significant challenge.
The Path from Pre-Seed
For now, Dexorder is a filing and a GitHub repo. The $50,000 raise is the sole financial marker [formds.com, Nov 2025]. The next 12 months will test whether a purely on-chain, noncustodial order book can attract enough volume to justify its own existence. Key milestones to watch include the launch on additional L2s, the first public integration with a wallet or aggregator, and any on-chain data showing consistent use.